Company intelligence / Profile preview

Levitate Bio

Ownership: Private
Development stage: Other

Overview

Levitate Bio offers cloud-based automated protein modeling and design protocols leveraging AI and the Rosetta suite. It enables biopharma companies to accelerate drug discovery by providing customizable software solutions with professional support. The technology has been foundational in developing multiple IND-stage biologics at Cyrus Biotechnology and has been adopted by over 120 pharmaceutical companies globally through its predecessor platforms.

Modalities: ProteinBiologic
Industry: Drug Discovery Services

Partnerships

Cyrus Biotechnology is both an inaugural client and close collaborator.The company also maintains relationships with numerous pharma clients via its software/services but no specific major partnerships disclosed

Beyond the preview

Go deeper on Levitate Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Levitate Bio.

Explore the full profile